secwatch / observer
8-K filed May 8, 2023, 7:59 PM ET CIK 0001566469
regulatory confidence high sentiment negative materiality 0.80

NantHealth, Inc.: Nasdaq/NYSE listing notice — NantHealth receives Nasdaq delisting notice for failure to meet public float requirement

NantHealth, Inc.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.99

NantHealth, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C), 5810(c)(3)(A)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
market value
Rules
5450(b)(2)(C), 5810(c)(3)(A)
Exact text from the filing
May 2, 2023, the Company received written notice (the “Notice”) from Nasdaq stating that the Company has not complied with the Public Float Requirement prior to the expiration of the Compliance Period. The Notice indicated that Company’s common stock would be suspended from trading on Nasdaq on May 11, 2023. The Company may appeal the Staff’s determination to a Hearings Panel (the “Panel”), pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series, by requesting a hearing before the Panel by 4:00 p.m. Eastern Time on May 9, 2023. The Company intends to timely request a hearin
View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR
accession 0001566469-23-000024
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.